Back to Chronic Myelomonocytic Leukaemia

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

    RECRUITING → SUSPENDED

    Recorded 2026-10-01

    View record

  2. Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

    ACTIVE NOT RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record

  3. Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

    ACTIVE NOT RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record

  4. ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

    RECRUITING → SUSPENDED

    Recorded 2026-10-01

    View record

  5. A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

    RECRUITING → WITHDRAWN

    Recorded 2026-10-01

    View record